Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.06 USD | -0.75% | -1.50% | -18.26% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.26% | 3.13B | |
+6.52% | 32.61B | |
+22.28% | 7.98B | |
+25.15% | 3.99B | |
-19.67% | 1.38B | |
-31.26% | 1.2B | |
+7.37% | 959M | |
-33.44% | 915M | |
-25.36% | 819M | |
-18.08% | 700M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall